Security key
449778109
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBTQ)
CUSIP: 449778109
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 29,668,665
- Total 13F value
- $41,702,613
- Share change
- +17,421,886
- SEC-reported price per share
- $1.41
- Number of holders
- 19
- Value change
- +$24,426,263
- Number of buys
- 12
- Number of sells
- 6
- Shares outstanding
- 79,751,533
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
19
Top holders
10
IOBTQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
IO Biotech, Inc. SEC filings
IO Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 449778109
Recent filing periods:
Ownership snapshot
Top reported holders of IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Novo Holdings A/S
Disclosed value leader
Novo Holdings A/S
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 4.1%
Showing 1-6 of 15 holder rows.
Quick read
Novo Holdings A/S leads the comparable SEC ownership view at 4.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Novo Holdings A/S's linked filing trail.
Comparable ownership
Top 5
Novo Holdings A/S
4.1%
Vivo Capital, LLC
3.8%
Avoro Capital Advisors LLC
2.6%
BANK OF AMERICA CORP /DE/
2.3%
Samsara BioCapital, LLC
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
Company
|
4.1%
|
$6,408,357
3,277,932 shares
|
— | 30 Jun 2023 |
| Vivo Capital, LLC |
13F
Company
|
3.8%
|
$5,895,390
3,015,545 shares
|
— | 30 Jun 2023 |
| Avoro Capital Advisors LLC |
13F
Company
|
2.6%
|
$4,029,531
2,055,883 shares
|
— | 30 Jun 2023 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
2.3%
|
$3,624,932
1,854,185 shares
|
— | 30 Jun 2023 |
| Samsara BioCapital, LLC |
13F
Company
|
1.3%
|
$1,971,494
1,008,437 shares
|
— | 30 Jun 2023 |
| PFM Health Sciences, LP |
13F
Company
|
0.77%
|
$1,197,854
612,713 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
29,668,665
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
15
Q3 2023 holders
19
Holder diff
4
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend